Antiepileptic rufinamide and QTc interval shortening in a patient with long QT syndrome: case report.

Background: There is limited pharmacologic therapy to reduce the QT interval in hereditary long QT syndrome (LQTS).

Case Summary: We describe a child with Allan-Herndon-Dudley syndrome, Lennox-Gastaut epileptic syndrome (LGS), and LQTS Type 1 (LQTS1). Rufinamide was added to his antiepileptic medications to improve seizure control and was noted to be associated with a marked improvement in electrocardiogram QT interval.

Narrowing the Protein Deficit Gap in Critically Ill Patients Using a Very High-Protein Enteral Formula.

Background: Protein deficits have been associated with longer intensive care unit (ICU) stays and increased mortality. Current view suggests if protein goals are met, meeting full energy targets may be less important and prevent deleterious effects of overfeeding. We proposed a very-high protein (VHP) enteral nutrition (EN) formula could provide adequate protein, without overfeeding energy, in the first week of critical illness.

Ultrasound Guidance in Femoral Artery Catheterization: A Systematic Review and a Meta-Analysis of Randomized Controlled Trials.

Background: During percutaneous cardiac procedures, the use of radial access is growing, but femoral access remains needed for large-bore, high-risk procedures. Methods are needed to make femoral access safer. In this systematic review and meta-analysis of randomized-controlled trials (RCTs), we assess whether ultrasound guidance is associated with a decreased risk of vascular complications during femoral artery catheterization.

Primary and rescue percutaneous coronary intervention with paclitaxel-eluting stent implantation in ST-elevation myocardial infarction.

We conducted a retrospective comparison of paclitaxel-eluting stents (PESs, n = 60) versus bare metal stents (BMSs, n = 137) in consecutive patients who underwent primary or rescue percutaneous coronary intervention over 1 year. The PES cohort had no in-stent thromboses and had a 65% (p = 0.02) decrease in the combined end point of death, recurrent myocardial infarction, and target vessel revascularization at 1 year compared with the BMS group.

A case of primary malignant pericardial mesothelioma.

Primary malignant pericardial mesothelioma (PMPM) is an exceedingly rare tumour. One of the largest necropsy series gave an incidence of primary pericardial tumours of 0.0022%, of which mesothelioma is the most common type.